Login / Signup

Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study.

Jürgen PannekKarel EveraertSandra MöhrWill VanceFrank Van der AaJürg Kesselring
Published in: BMC urology (2020)
ClinicalTrials.gov ( NCT02157415 ), June 6th, 2014.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • randomized controlled trial
  • clinical trial
  • patient reported outcomes